CLOSED

GET A PIECE OF CALIBRE BIOMETRICS

Unlock the data in your breath

Calibre® is on a mission to democratize access to respiratory and metabolic data. By revolutionizing breath measurement through our affordable, ultralight wearable device, we believe we can make respiratory data available to millions with applications for fitness training, wellness, and eventually a wide variety of medical uses. Our product has recently been launched and is now shipping to customers.

Show more

This Reg CF offering is made available through StartEngine Capital, LLC. This investment is speculative, illiquid, and involves a high degree of risk, including the possible loss of your entire investment.
Company Image

TEAM

Udi Meirav

Udi Meirav • CEO and Founder

Calibre is the brainchild of Udi Meirav, a prolific inventor and seasoned startup CEO. Starting his career as a PhD Physicist from MIT - specializing in semiconductors - Udi evolved as a tech entrepreneur and executive, leading several startups that have brought complex, novel products to market. One of his recent companies developed air cleaning technology that reduces the amount of energy required for air conditioning, now installed in buildings around the world. He has dozens of patents to his name. Several years ago he became fascinated with the biometric significance of breath and the potential of wearable breath sensors, an idea that eventually evolved into the metabolic tracker called Calibre, which is his current passion. Udi and his wife Megan have 6 children and live near Boston.

Read More

Raviv Shefet

Raviv Shefet • Chief Financial Officer

Raviv is a seasoned financial exective with 25 years’ experience in U.S. and international financial and operations management, spanning the gamut from early stage venture-capital backed startups to mature, profitable businesses and publicly traded companies. His track record as CFO includes technology companies in software and hardware, among them Charidy, 33Across, WebCollage, DVTel and Selway Partners (SCP).

Read More

David Ierardi

David Ierardi • Chief Operating Officer

Dave brings over 30 years of product development and manufacturing scale-up experience in a multitude of industries including telecommunications, consumer electronics, military electronics, fuel cell technology and battery materials. He has a strong track record working at the highest levels of numerous organization in manufacturing and engineering leadership. With an educational background in mechanical engineering and computer integrated manufacturing, he has operated in a broad number of disciplines including electronics, materials, software and has built and led multidisciplinary teams. Dave has an unmistakeable passion for product development and large scale, high quality production.

Read More


Reasons to Invest

  • Differentiated and protected technology - Calibre provides scalable access to accurate and informative respiratory data that was previously only available in labs or hospitals. This is achieved with an innovative, wearable product that can be used by anyone, enabled by revolutionary technology that is protected by multiple patents.
  • Early move in greenfield space - We believe Calibre to be one of the first to bring breath-based wearables to the consumer market in a scalable way - democratizing access to respiratory data,  and in doing so establishing an entirely new - and very large - space in the digital health data market.
  • Remarkable upside opportunity - Calibre’s founding team has successfully taken the product through development, manufacturing, and beta testing - and is now shipping regularly to customers - all on a relatively shoestring budget, allowing Calibre to offer a ground-floor investment opportunity with enormous upside.




Overview


The future of respiratory data is Calibre


Respiratory data has been enormously interesting to medical science but out of reach for most people. At Calibre, we aim to provide an accessible way for anyone to track and collect this data whenever and wherever they would like to. The implications are groundbreaking and amazing.

Combining established respiratory science with breakthrough technology, we believe Calibre empowers users to take charge of their metabolism, respiratory wellness, and much more.



Through our game-changing design and technology, Calibre enables respiratory data access to anyone, simply, on a cloud-enabled app. In other words, we are unlocking a hidden trove of personal metabolic and physiological data for millions.

THE Problem & OUR solution


Biometrics of human breath have been appreciated for over a century, but the data has been out of reach for most people


Breath data has been historically only accessible for professional use in laboratory settings, utilizing expensive, cumbersome, complex equipment.



Calibre solves all these issues, thereby unleashing a whole new market. 


Proven science shows all our calories are “burned” using oxygen and producing CO2 - that’s breath! Calibre makes this established insight available to everybody - accurately tracking calories used per minute by measuring the oxygen and C02 in exhaled breath. It can even distinguish fat burn from carb burn, isn’t that cool? And perhaps most remarkable, this works in any activity and for any body type. All on your phone, anytime you want.



We are aware that respiratory monitoring machines have been available for years, but they can cost from $10k upwards to $100k - where at Calibre our device is under $400 and usable anywhere. Currently, we are engaged in a B2C model that provides 1:1 sales; however, it is our goal to also offer our products at a large scale through  institutions, sports programs, and various partnerships.


Act 2 - Medical Use


Calibre provides an easy way for breath data to be collected securely in real-time to the cloud. As such, we feel Calibre can become extremely beneficial in medical and clinical settings in the not-too-distant future. Calibre could provide caregivers remote patient monitoring capabilities for a range of conditions and purposes ranging from pulmonary and cardiovascular health to sleep and neurological issues. We also believe that Calibre can be a powerful tool for clinical research on a new scale, in terms of what and how participants, can be studied using Calibre devices. At the moment Calibre is not an FDA-approved medical device, but we are planning to apply for FDA clearance in the near future.

The market & Our Traction


The wearables market was valued at more than $100 Billion in 2021* - we believe Calibre is positioned to be an industry leader in its sector 


In this expanding market, we feel there has been a glaring absence of products to monitor and track respiratory data. Calibre's technology has the potential to fill that gap and offer key insights through the data collected.


The global wearable technology market size is projected to grow at a compound annual growth rate of 13.89% to reach around $392.4 Billion during the forecast period of 2022 to 2030 (source), and wearable devices specifically in consumer applications could skyrocket up to $212.67 Billion by 2029 (source).



Calibre aims to be an industry leader in these growing markets, and we believe we have made significant headway towards that goal. In anticipation of such potential, we have filed multiple patents (8 pending, one already issued).


Here’s a look at more of our traction...





WHY INVEST


Calibre is on a mission to expand and make respiratory data more accessible for all


We feel that Calibre is poised to disrupt the wearables and digital health market, and believe that our technology's application can expand tremendously with the financial support we need to get there.



Our longer-term vision is to “get serious” about the medical opportunities - moving towards FDA certification, hiring the right experts, and, above all, engaging the medical community.



Calibre is bringing something unique, novel, affordable, and accessible to the market - we believe everyone can have access to their respiratory data through user-friendly wearable technology. Join in on the mission and invest today!




Code View

ABOUT

HEADQUARTERS
35 Walnut Street, Suite 100
Wellesley Hills, MA 02481
WEBSITE
View Site
Calibre® is on a mission to democratize access to respiratory and metabolic data. By revolutionizing breath measurement through our affordable, ultralight wearable device, we believe we can make respiratory data available to millions with applications for fitness training, wellness, and eventually a wide variety of medical uses. Our product has recently been launched and is now shipping to customers.

TERMS

Calibre Biometrics
Overview
PRICE PER SHARE
$2.50
DEADLINE
Mar. 21, 2023 at 6:59 AM UTC
VALUATION
$22.75M
FUNDING GOAL
$15K - $1.24M
Breakdown
MIN INVESTMENT
$500
MAX INVESTMENT
$1,235,000
MIN NUMBER OF SHARES OFFERED
6,000
MAX NUMBER OF SHARES OFFERED
494,000
OFFERING TYPE
Equity
SHARES OFFERED
Class A Common Stock

Maximum Number of Shares Offered subject to adjustment for bonus shares

A crowdfunding investment involves risk. You should not invest any funds in this offering unless you can afford to lose your entire investment. In making an investment decision, investors must rely on their own examination of the issuer and the terms of the offering, including the merits and risks involved. These securities have not been recommended or approved by any federal or state securities commission or regulatory authority. Furthermore, these authorities have not passed upon the accuracy or adequacy of this document. The U.S. Securities and Exchange Commission does not pass upon the merits of any securities offered or the terms of the offering, nor does it pass upon the accuracy or completeness of any offering document or literature. These securities are offered under an exemption from registration; however, the U.S. Securities and Exchange Commission has not made an independent determination that these securities are exempt from registration.

*Maximum number of shares offered subject to adjustment for bonus shares. See Bonus info below.

Investment Incentives and Bonuses*

Time-Based:

Friends and Family Early Birds

Invest within the first 96 hours and receive 20% bonus shares.

Super Early Bird Bonus

Invest within the first week and receive 15% bonus shares.

Early Bird Bonus

Invest within the first three weeks and receive 10% bonus shares.

Amount-Based:

$1000 + / Supporter

Invest $1,000 and receive 2% Bonus Shares.

$2,500+ | VIP

Invest $2,500 + and receive 5% Bonus Shares.

$5,000 + | VIP + 10 % Bonus Shares

Invest $5,000+ and receive 10 % Bonus Shares, Free product.

 

$10,000+ | VIP Gold

Invest $10,000+ and receive 15% Bonus Shares, Free product, coaching session with Sean (Co-Founder/Master Instructor).

 

$25,000+ | VIP Platinum

Invest $25,000+ and receive 20% Bonus Shares + Private zoom call with Chief Executive Officer, Free product, coaching session with Sean (Co-Founder/Master Instructor).  

*In order to receive perks from an investment, one must submit a single investment in the same offering that meets the minimum perk requirement. Bonus shares from perks will not be granted if an investor submits multiple investments that, when combined, meet the perk requirement. All perks occur when the offering is completed.

The 10% StartEngine Owners' Bonus

Calibre Biometrics Inc. will offer 10% additional bonus shares for all investments that are committed by investors that are eligible for the StartEngine Crowdfunding Inc. OWNer's bonus.

This means eligible StartEngine shareholders will receive a 10% bonus for any shares they purchase in this offering. For example, if you buy 100 shares of Class A Common Stock at $2.50 / share, you will receive 110 shares of Class A Common Stock, meaning you'll own 110 shares for $250. Fractional shares will not be distributed and share bonuses will be determined by rounding down to the nearest whole share.

This 10% Bonus is only valid during the investors eligibility period. Investors eligible for this bonus will also have priority if they are on a waitlist to invest and the company surpasses its maximum funding goal. They will have the first opportunity to invest should room in the offering become available if prior investments are canceled or fail.

Investors will receive the highest single bonus they are eligible for among the bonuses based on the amount invested and time of offering elapsed (if any). Eligible investors will also receive the Owner’s Bonus in addition to the aforementioned bonus.

Irregular Use of Proceeds

The Company might incur Irregular Use of Proceeds that may include but are not limited to the following over $10,000: Vendor payments.

ALL UPDATES

REWARDS

Multiple investments in an offering cannot be combined to qualify for a larger campaign reward.

10%

Stack Venture Club & Rewards!

Members get an extra 10% shares in addition to rewards below!

Venture Club

Venture Club

Venture Club Members earn 10% bonus shares on top of this and all eligible investments for an entire year. Not a member? Sign up at checkout ($275/year).

$1,000

Supporter

Invest $1,000 and receive 2% Bonus Shares.

$2,500

VIP

Invest $2,500 + and receive 5% Bonus Shares.

$5,000

VIP + 10 % Bonus Shares

Invest $5,000+ and receive 10 % Bonus Shares, Free product.

$10,000

VIP Gold

Invest $10,000+ and receive 15% Bonus Shares, Free product, coaching session with Sean (Co-Founder/Master Instructor).

$25,000

VIP Platinum

Invest $25,000+ and receive 20% Bonus Shares + Private zoom call with Chief Executive Officer, Free product, coaching session with Sean (Co-Founder/Master Instructor).

@ 2025 All Rights Reserved

Apple App Store Badge
Google Play Store Badge

Get To Know Us

Our Team

Careers

Blog

Let's Work Together

Raise Capital

Refer a Founder, earn $10k

Success Stories

Partnerships

Need Help

Contact Us

Help Center

Terms of Use

Privacy Policy

Disclaimer

Annual Reports

Form CRS

Reg. BI Disclosure

Terms of Use

Privacy Policy

Disclaimer

Annual Reports

Form CRS

Reg. BI Disclosure

Important Message

IN MAKING AN INVESTMENT DECISION, INVESTORS MUST RELY ON THEIR OWN EXAMINATION OF THE ISSUER AND THE TERMS OF THE OFFERING, INCLUDING THE MERITS AND RISKS INVOLVED. INVESTMENTS ON STARTENGINE ARE SPECULATIVE, ILLIQUID, AND INVOLVE A HIGH DEGREE OF RISK, INCLUDING THE POSSIBLE LOSS OF YOUR ENTIRE INVESTMENT.

www.StartEngine.com is a website owned and operated by StartEngine Crowdfunding, Inc. (“StartEngine”), which is neither a registered broker-dealer, investment advisor nor funding portal.

Unless indicated otherwise with respect to a particular issuer, all securities-related activity is conducted by regulated affiliates of StartEngine: StartEngine Capital LLC, a funding portal registered here with the US Securities and Exchange Commission (SEC) and here as a member of the Financial Industry Regulatory Authority (FINRA), or StartEngine Primary LLC (“SE Primary”), a broker-dealer registered with the SEC and FINRA / SIPC. You can review the background of our broker-dealer and our investment professionals on FINRA’s BrokerCheck here. StartEngine Secondary is an alternative trading system (ATS) regulated by the SEC and operated by SE Primary. SE Primary is a member of SIPC and explanatory brochures are available upon request by contacting SIPC at (202) 371-8300.

StartEngine facilitates three types of primary offerings:

1) Regulation A offerings (JOBS Act Title IV; known as Regulation A+), which are offered to non-accredited and accredited investors alike. These offerings are made through StartEngine Primary, LLC (unless otherwise indicated). 2) Regulation D offerings (Rule 506(c)), which are offered only to accredited investors. These offerings are made through StartEngine Primary, LLC. 3) Regulation Crowdfunding offerings (JOBS Act Title III), which are offered to non-accredited and accredited investors alike. These offerings are made through StartEngine Capital, LLC. Some of these offerings are open to the general public, however there are important differences and risks.

Any securities offered on this website have not been recommended or approved by any federal or state securities commission or regulatory authority. StartEngine and its affiliates do not provide any investment advice or recommendation and do not provide any legal or tax advice concerning any securities. All securities listed on this site are being offered by, and all information included on this site is the responsibility of, the applicable issuer of such securities. StartEngine does not verify the adequacy, accuracy, or completeness of any information. Neither StartEngine nor any of its officers, directors, agents, and employees makes any warranty, express or implied, of any kind whatsoever related to the adequacy, accuracy, or completeness of any information on this site or the use of information on this site.

Investing in private company securities is not suitable for all investors. An investment in private company securities is highly speculative and involves a high degree of risk. It should only be considered a long-term investment. You must be prepared to withstand a total loss of your investment. Private company securities are also highly illiquid, and there is no guarantee that a market will develop for such securities. Each investment also carries its own specific risks, and you should complete your own independent due diligence regarding the investment. This includes obtaining additional information about the company, opinions, financial projections, and legal or other investment advice. Accordingly, investing in private company securities is appropriate only for those investors who can tolerate a high degree of risk and do not require a liquid investment. See additional general disclosures here.

By accessing this site and any pages on this site, you agree to be bound by our Terms of use and Privacy Policy, as may be amended from time to time without notice or liability.

Canadian Investors

Investment opportunities posted and accessible through the site will not be offered to Canadian resident investors. Potential investors are strongly advised to consult their legal, tax and financial advisors before investing. The securities offered on this site are not offered in jurisdictions where public solicitation for offerings is not permitted; it is solely your responsibility to comply with the laws and regulations of your country of residence.

California Investors Only – Do Not Sell My Personal Information (800-317-2200). StartEngine does not sell personal information. For all customer inquiries, please write to contact@startengine.com.

StartEngine Marketplace

StartEngine Marketplace (“SE Marketplace”) is a website operated by StartEngine Primary, LLC (“SE Primary”), a broker-dealer that is registered with the SEC and a member of FINRA and the SIPC.

StartEngine Secondary (“SE Secondary”) is our investor trading platform. SE Secondary is an SEC-registered Alternative Trading System (“ATS”) operated by SE Primary that matches orders for buyers and sellers of securities. It allows investors to trade shares purchased through Regulation A+, Regulation Crowdfunding, or Regulation D for companies who have engaged StartEngine Secure LLC as their transfer agent. The term “Rapid,” when used in relation to transactions on SE Marketplace, specifically refers to transactions that are facilitated on SE Secondary, This is because, unlike with trades on the StartEngine Bulletin Board (“SE BB”), trades on SE Secondary are executed the moment that they are matched.

StartEngine Bulletin Board (“SE BB”) is a bulletin board platform on which users can indicate to each other their interest to buy or sell shares of private companies that previously executed Reg CF or Reg A offerings not necessarily through SE Primary. As a bulletin board platform, SE BB provides a venue for investors to access information about such private company offerings and connect with potential sellers. All investment opportunities on SE BB are based on indicated interest from sellers and will need to be confirmed. Even if parties express mutual interest to enter into a trade on SE BB, a trade will not immediately result because execution is subject to additional contingencies, including among others, effecting of the transfer of the shares from the potential seller to the potential buyer by the issuer and/or transfer agent. SE BB is distinct and separate from SE Secondary. SE Secondary facilitates the trading of securities by matching orders between buyers and sellers and facilitating executions of trades on the platform. By contrast, under SE BB, SE Primary assists with the facilitation of a potential resulting trade off platform including, by among other things, approaching the issuer and other necessary parties in relation to the potential transaction. The term “Extended”, when used in relation to transactions on SE Marketplace denotes that these transactions are conducted via SE BB, and that these transactions may involve longer processing times compared to SE Secondary for the above-stated reasons.

Even if a security is qualified to be displayed on SE Marketplace, there is no guarantee an active trading market for the securities will ever develop, or if developed, be maintained. You should assume that you may not be able to liquidate your investment for some time or be able to pledge these shares as collateral.

The availability of company information does not indicate that the company has endorsed, supports, or otherwise participates with StartEngine. It also does not constitute an endorsement, solicitation or recommendation by StartEngine. StartEngine does not (1) make any recommendations or otherwise advise on the merits or advisability of a particular investment or transaction, (2) assist in the determination of the fair value of any security or investment, or (3) provide legal, tax, or transactional advisory services.